Kyverna Therapeutics Inc.

2.16
0.03 (1.41%)
At close: Apr 24, 2025, 3:59 PM

Kyverna Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
n/a n/a n/a n/a n/a n/a n/a n/a 282K
n/a n/a 530K 482K 462K 438K 413K 8.71M 374K
n/a n/a -530K -482K -462K -438K -413K -8.71M -92K
-41.04M -38.77M -33.44M -29.36M -21.38M -16.28M -13.3M -11.45M -8.78M
3.58M 4.36M 4.69M 2.73M 789K 880K 264K 349K 297K
-37.49M -34.49M -28.8M -26.69M -20.67M -15.46M -13.09M -11.14M -8.5M
-37.49M -34.49M -28.8M -26.69M -20.67M -15.46M -13.09M -11.14M -8.5M
7.56M 9.58M 6.11M 6.88M 4.21M 2.64M 2.9M 2.73M 1.99M
33.48M 29.19M 27.32M 22.48M 17.16M 13.21M 9.99M 8.71M 7.07M
n/a n/a n/a -26K -32K -13K -7K -3K 23K
41.04M 38.77M 33.44M 29.36M 21.38M 15.84M 12.89M 11.45M 9.06M
27K 32K 39K 44K 47K 50K 46K 44K 41K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
41.04M 38.77M 33.44M 29.36M 21.38M 16.28M 13.3M 11.45M 9.06M
n/a n/a n/a 18K 15K n/a n/a 41K 64K
40.75M 43.16M 43.13M 23.75M 43.12M 43.12M 43.12M 25.8M 43.12M
40.75M 43.16M 43.13M 23.75M 43.12M 43.12M 43.12M 25.8M 43.12M
-0.92 -0.8 -0.67 -1.12 -0.48 -0.36 -0.3 -0.43 -0.2
-0.92 -0.8 -0.67 -1.12 -0.48 -0.36 -0.3 -0.43 -0.2
-36.9M -33.9M -28.23M -26.17M -20.16M -14.98M -12.63M -10.71M -8.08M
-37.46M -34.46M -28.76M -26.65M -20.62M -15.41M -13.04M -11.1M -8.46M
563K 558K 530K 482K 462K 438K 413K 394K 374K